NutriBand (NTRB) Amortizatization of Intangibles (2017 - 2023)
NutriBand's (NTRB) quarterly Amortizatization of Intangibles came in at $7845.0 in Q3 2023, down 47.64% year-on-year from $14982.0 in Q3 2022, and little changed quarter-over-quarter from $7845.0 in Q2 2023.
NutriBand (NTRB) Amortizatization of Intangibles (2017 - 2023) Analysis & Trends
NutriBand has disclosed Amortizatization of Intangibles across 6 years of filings, most recently posting $7845.0 for Q3 2023.
- Amortizatization of Intangibles for Q3 2023 came in at $7845.0, down 47.64% year-over-year; the trailing twelve-month figure through Jul 2023 was $24536.0 (down 54.84% YoY), and the FY2023 annual result was $38813.0, down 60.18% from the prior year.
- Amortizatization of Intangibles came in at $7845.0 for Q3 2023 at NutriBand, roughly flat from $7845.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $197695.0 in Q3 2020 to a low of -$3765.0 in Q1 2023.
- The 5-year median for Amortizatization of Intangibles is $14982.0 (2022), against an average of $41453.7.
- Across the five-year window, Amortizatization of Intangibles surged 4212.72% in 2020 and slumped 81.51% in 2021, its largest moves.
- NutriBand's Amortizatization of Intangibles stood at $4584.0 in 2019, then soared by 4212.72% to $197695.0 in 2020, then slumped by 87.67% to $24369.0 in 2021, then tumbled by 48.25% to $12611.0 in 2022, then slumped by 37.79% to $7845.0 in 2023.
- The last three Amortizatization of Intangibles figures came in at $7845.0 (Q3 2023), $7845.0 (Q2 2023), and -$3765.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | NutriBand | 40.74 Mn | 36.17 Mn | 88,941.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2023 | 7,845.00 |
| Jul 31, 2023 | 7,845.00 |
| Apr 30, 2023 | 7,845.00 |
| Apr 30, 2023 | 7,845.00 |
| Jan 31, 2023 | -3,765.00 |
| Jan 31, 2023 | -3,765.00 |
| Oct 31, 2022 | 12,611.00 |
| Oct 31, 2022 | 12,611.00 |
| Jul 31, 2022 | 14,982.00 |
| Jul 31, 2022 | 14,982.00 |
| Apr 30, 2022 | 14,985.00 |
| Apr 30, 2022 | 14,985.00 |
| Oct 31, 2021 | 24,369.00 |
| Oct 31, 2021 | 24,369.00 |
| Jul 31, 2021 | 36,554.00 |
| Jul 31, 2021 | 36,554.00 |
| Apr 30, 2021 | 36,554.00 |
| Apr 30, 2021 | 36,554.00 |
| Jan 31, 2021 | 69,630.00 |
| Jan 31, 2021 | 69,630.00 |